Clinical Trial Update: Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing Zelquistinel to placebo for reducing symptoms of Major Depressive Disorder; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Zelquistinel (Zelquistinel)

Snippet

Sponsor: Syndeio Biosciences, Inc | Conditions: Major Depressive Disorder | Phase 2 | Status: RECRUITING